Hemorrhoidex

Aesculus Hipp, Collinsonia, Hamamelis

Nartex Laboratorios Homeopaticos Sa De Cv
Human Otc Drug
NDC 34666-191

Hemorrhoidex also known as Aesculus Hipp, Collinsonia, Hamamelis is a human otc drug labeled by 'Nartex Laboratorios Homeopaticos Sa De Cv'. National Drug Code (NDC) number for Hemorrhoidex is 34666-191. This drug is available in dosage form of Tablet. The names of the active, medicinal ingredients in Hemorrhoidex drug includes Collinsonia Canadensis Root - 6 [hp_C]/1 Hamamelis Virginiana Root Bark/stem Bark - 6 [hp_C]/1 Horse Chestnut - 6 [hp_C]/1 . The currest status of Hemorrhoidex drug is Active.

Drug Information:

Drug NDC:	34666-191
The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
Proprietary Name:	Hemorrhoidex
Also known as the trade name. It is the name of the product chosen by the labeler.
Product Type:	Human Otc Drug
Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing.
Non Proprietary Name:	Aesculus Hipp, Collinsonia, Hamamelis
Also known as the generic name, this is usually the active ingredient(s) of the product.
Labeler Name:	Nartex Laboratorios Homeopaticos Sa De Cv
Name of Company corresponding to the labeler code segment of the ProductNDC.
Dosage Form:	Tablet
The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources.
Status:	Active
FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved.
Substance Name:	COLLINSONIA CANADENSIS ROOT - 6 [hp_C]/1 HAMAMELIS VIRGINIANA ROOT BARK/STEM BARK - 6 [hp_C]/1 HORSE CHESTNUT - 6 [hp_C]/1
This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted.
Route Details:	ORAL
The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.

Marketing Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Marketing Category:	UNAPPROVED HOMEOPATHIC
Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
Marketing Start Date:	01 Mar, 2015
This is the date that the labeler indicates was the start of its marketing of the drug product.
Marketing End Date:	12 Jun, 2026
This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
Listing Expiration Date:	31 Dec, 2023
This is the date when the listing record will expire if not updated or certified by the firm.

OpenFDA Information:

An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.

Manufacturer Name:	Nartex Laboratorios Homeopaticos SA DE CV
Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC.
Original Packager:	Yes
Whether or not the drug has been repackaged for distribution.
UPC:	0844827000382
UPC stands for Universal Product Code.
UNII:	O2630F3XDR T7S323PKJS 3C18L6RJAZ
Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information.

Packaging Information:

Package NDC	Description	Marketing Start Date	Marketing End Date	Sample Available
34666-191-12	12 TABLET in 1 CARTON (34666-191-12)	01 Mar, 2018	N/A	No
34666-191-30	30 TABLET in 1 CARTON (34666-191-30)	01 Mar, 2015	N/A	No
Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together.

Other medicines with the same generic name

Hemorrhoidex

Aesculus Hipp, Collinsonia, Hamamelis

Tablet
Nartex Laboratorios Homeopaticos SA DE CV
NDC: 34666-191

Purpose:

Purpose aesculus hipp......6c hpus....................hemorrhoids, pain after stool, aching, swollen, burning in anus collinsonia...........6c hpus....................hemorrhoids, itching or burning in anus with swelling hamamelis..........6c hpus.....................hemorrhoids, pulsation in rectum the letters "hpus" indicate that the components in this product are officially monographed in the homeopathic pharmacopoeia of the united states. c is a homeopathic dilution: see www.nartexlabusa.com for details.

Product Elements:

Hemorrhoidex aesculus hipp, collinsonia, hamamelis gelatin lactose magnesium stearate starch, potato sodium benzoate talc horse chestnut horse chestnut collinsonia canadensis root collinsonia canadensis root hamamelis virginiana root bark/stem bark hamamelis virginiana root bark/stem bark none nartex logo none

Indications and Usage:

Uses temporarily relieves discomforting symptoms such as itching, burning, and swelling associated with hemorrhoids. product claims and uses have not been evaluated by the food and drug administration. this product has not been clinically tested by nartex labs usa, inc.

Warnings:

Warnings do not use if you have an allergy or hypersensitivity to components of the formula or if you have had a prior reaction to this product. ask a doctor before use if you are under a doctor's care for any serious condition taking any other drug when using this product do not exceed the recommended daily dosage unless directed by a physician stop use and ask a doctor if symptoms persist, worsen, or if new symptoms occur after 7 days rash develops if pregnant or breast feeding , ask a health professional before use. keep out of reach of children. in case of overdose, get medical help or contact a poison control center right away.

When Using:

When using this product do not exceed the recommended daily dosage unless directed by a physician

Dosage and Administration:

Directions adults and children over 12 years, take 2 tablets every 6 hours children under 12 years of age, consult a physician

Stop Use:

Stop use and ask a doctor if symptoms persist, worsen, or if new symptoms occur after 7 days rash develops

Package Label Principal Display Panel:

Hemorrhoidex homeopathic hemorrhoid tablets temporarily relieves discomforting symptoms such as itching, burning, and swelling associated with hemorrhoids 30 tablets hemorrhoidex label

Further Questions:

Questions or comments? 1-877-248-1970, between 9am and 5pm pt. informacion@nartexlabs.com

Comments/ Reviews:

* Data of this site is collected from www.fda.gov. This page is for informational purposes only. Always consult your physician with any questions you may have regarding a medical condition.